SIGA Technologies, Inc.

NASDAQ:SIGA

Drug Manufacturers - Specialty & Generic

Healthcare
$2.80 -0.36%

-$0.02 today

Market cap
$201.19M
Beta
0.85
P/E (TTM)
15.2
EPS (TTM)
$0.28
Dividend yield
13.97%
52W Low $4.10High $9.62

Volume 0.37M

Average 0.61M

SIGA Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

SIGA Technologies, Inc.NASDAQ: SIGA

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin narrows to -55.3%

Net margin was -55.3% in Q1 FY2026, down 49.5 pp from a year earlier. On a trailing-twelve-month basis it was 21.6%, down 18.7 pp year over year. Over 3 fiscal years it narrowed by 6.0 pp.

Context

  • Net margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 1 analysts of 227.3% for the fiscal year ending Dec 2026, up from 24.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-55.3%+86.8 pp QoQ
Last fiscal yearDec 2025
24.6%-18.1 pp YoY
LTMMar 2026
21.6%-18.7 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-49.5 pp——
1 year-18.1 pp+202.7 pp+220.7 pp
3 years-6.0 pp——
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
24.6%
Year-over-year change
-18.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How SIGA compares with its peers on the latest reported figures

  • SIGA's LTM Mar 2026 net margin of 21.6% is the 3rd highest of the 9 companies compared; the peer median is -1.2%.
  • Its year-over-year change of -18.7 pp is the 7th highest of 9, against a peer median of +11.4 pp.
  • Over three fiscal years its change of -6.0 pp compares with a peer median of +41.9 pp.
SIGA Competitors Peer median
Net Margin for SIGA and competitors
Company Period LTM level YoY 3-year change
DRIODarioHealth Corp.LTM Mar 2026295.9% +455.7 pp+38.3 pp
RIGLRigel Pharmaceuticals, Inc.LTM Mar 2026121.5% +103.2 pp+173.4 pp
SIGASIGA Technologies, Inc.LTM Mar 202621.6% -18.7 pp-6.0 pp
ORGOOrganogenesis Holdings Inc.LTM Mar 2026-0.1% +3.4 pp+3.1 pp
SNDLSNDL Inc.LTM Mar 2026-1.2% +10.4 pp+45.4 pp
EBSEmergent BioSolutions Inc.LTM Mar 2026-1.3% +12.4 pp+26.0 pp
ESPREsperion Therapeutics, Inc.LTM Mar 2026-1.8% +57.3 pp+304.0 pp
AQSTAquestive Therapeutics, Inc.LTM Mar 2026-137.1% -37.1 pp-74.0 pp
CTMXCytomX Therapeutics, Inc.LTM Mar 2026-166.4% -194.6 pp+164.0 pp
OLMAOlema Pharmaceuticals, Inc.FY2025— ——
Peer median (excluding SIGA) -1.2%+11.4 pp+41.9 pp

Competitors are the stored peer set for SIGA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue133.67M110.78M139.92M138.72M94.6M
Cost of Revenue16.6M10.43M17.83M31.29M29.7M
Gross Profit117.07M100.34M122.09M107.43M64.87M
Gross Margin87.6%90.6%87.3%77.4%68.6%
Research & Development9.94M22.53M16.43M12.31M6.53M
Selling, General & Admin18.03M35.12M22.04M25.14M3.13M
Operating Expenses27.98M57.64M38.47M37.45M41.17M
Depreciation & Amortization522.37K517.64K538.29K538.42K562.61K
EBITDA89.83M44.65M88.31M76.61M30.96M
EBITDA Margin67.2%40.3%63.1%55.2%32.7%
Operating Income89.09M42.7M83.62M69.98M23.7M
Operating Margin66.7%38.5%59.8%50.4%25.1%
Interest Income00006.68M
Interest Expense00000
Other Income / Expenses218.94K1.43M4.16M6.09M6.7M
Income Before Tax89.31M44.13M87.78M76.07M30.4M
Pre-Tax Margin66.8%39.8%62.7%54.8%32.1%
Income Tax Expense19.86M10.23M19.71M16.86M7.1M
Net Income69.45M33.9M68.07M59.21M23.3M
Net Margin52.0%30.6%48.6%42.7%24.6%
EPS (Basic)0.920.460.950.830.33
EPS (Diluted)0.910.460.950.830.33
Weighted Avg Shares75.32M72.93M71.36M71.25M71.6M
Weighted Avg Shares (Diluted)76.4M73.55M71.68M71.77M71.6M

SIGA Technologies, Inc.

NASDAQ:SIGA

Intrinsic Alpha fair value

Locked

Current Price

$2.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.